Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 117 of the 119 references it cites were found in a registry or an index.

Statins as Anticancer Agents in the Era of Precision Medicine

Abstract

Statins are widely prescribed cholesterol-lowering drugs that inhibit HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate metabolic pathway. Multiple lines of evidence indicate that certain cancers depend on the mevalonate pathway for growth and survival, and, therefore, are vulnerable to statin therapy. However, these immediately available, well-tolerated, and inexpensive drugs have yet to be successfully repurposed and integrated into cancer patient care. In this review, we highlight recent advances and outline important considerations for advancing statins to clinical trials in oncology.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-20-1967

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 119 references

Cited by

See all 200

Metadata

Authors
Longo, J., van Leeuwen, J. E., Elbaz, M., Branchard, E., & Penn, L. Z.
Affiliations
University Health Network (CA)
Corresponding author
Penn, Linda Z.
Venue
Clinical Cancer Research
Published
2020-11-13
Volume
26
Issue
22
Pages
5791-5800
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W3083506235
Cited by
196
References
119
Citations by year
2026: 17 · 2025: 37 · 2024: 41 · 2023: 30 · 2022: 41 · 2021: 30
FWCI
2.57
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Canadian Institutes of Health Research (FRN: 142263)
  • Terry Fox Research Institute (PPG-1064)
  • Canadian Cancer Society (#706394)
  • Office of the Assistant Secretary of Defense for Health Affairs (W81XWH-16-1-0068)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords
statins, anticancer agents, drug repurposing, HMG-CoA reductase inhibition, mevalonate pathway, cancer metabolism, precision medicine
MeSH terms
Antineoplastic Agents, Humans, Mevalonic Acid, Neoplasms, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Metabolic Networks and Pathways, Precision Medicine, Drug Repositioning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statins as Anticancer Agents in the Era of Precision Medicine. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-20-1967
The paper
Longo, J., van Leeuwen, J. E., Elbaz, M., Branchard, E., & Penn, L. Z. (2020). Statins as Anticancer Agents in the Era of Precision Medicine. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-20-1967

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.